Jan
2027
Paris Expo, Porte de Versailles - Hall 4 | Paris, France
Visit us
stand 4G72, General Zone & stand 4MR17, MATCH AND MEET LOUNGE
Zone

SHL Medical AG

Exhibitor at Pharmapack Europe 2027
About Us

SHL Medical is a pioneering leader in self-injection solutions, including autoinjectors and pen injectors. Headquartered in Switzerland with sites across three continents, we provide end-to-end services, from design and development through final assembly, labeling, and packaging, partnering with pharmaceutical companies to deliver self-injection systems that enable patients’ independence. As of 2025, SHL Medical has shipped more than 1.5 billion autoinjectors worldwide.

View SHL Medical's trademarks: https://www.shl-medical.com/trademarks

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Switzerland
  • Founded:
    1989
  • On CPHI since:
    2020
  • Certificates:
    2
  • Employees:
    5000+
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Medical Devices
Packaging & drug delivery
View company profile
Contact info
Show contact info Hide contact info
Event information
Pharmapack Europe 2027
  • 27 Jan 2027 - 28 Jan 2027
  • Paris Expo, Porte de Versailles - Hall 4 | Paris, France
  • Visit us at stand 4G72, General Zone

Products Featured at Pharmapack Europe 2027

  • Quanta pen

    Product Quanta pen

    Quanta pen injector is developed for once-weekly cardiometabolic therapies. It integrates an automatic mechanism with a fixed, multi-dose configuration, offering 4-6 doses in a single device.

    Grounded in SHL Medical's experience in the field, Quanta provides pharma partners with another delivery opt...
  • Reunite autoinjector

    Product Reunite autoinjector

    Reunite is an innovative, three-step, dual-chamber cartridge autoinjector, built with our market-proven Needle isolation Technology (NIT), to support automated reconstitution and delivery of lyophilized formulations.
  • Molly modular platform autoinjector

    Product Molly modular platform autoinjector

    Molly is a single-dose, pre-filled syringe-based autoinjector developed to help pharma and biotech companies reduce initial investments and expedite development timelines. Built on a modular platform technology, Molly is designed to meet the evolving requirements of future autoinjectors, such as intro...
  • Molly 2.25 modular platform autoinjector

    Product Molly 2.25 modular platform autoinjector

    Molly 2.25 is a large-volume variant of the Molly autoinjector, developed to support the delivery of larger-volume biologics with the same 2-step operation. Built on a modular platform, Molly 2.25 enables high-volume manufacturing, faster development, and flexible design for unique branding needs...
  • Maggie autoinjector

    Product Maggie autoinjector

    Maggie is a cartridge-based autoinjector built with our market-proven Needle Isolation Technology (NIT). Maggie accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors.

SHL Medical Resources (1)

  • Your drug delivery partner with proven track record

    Brochure Your drug delivery partner with proven track record

    From design to mass production, SHL Medical's end-to-end device development infrastructure ensures the lasting value of self-injection systems that we design and develop with our customers. Our comprehensive in-house manufacturing capabilities and expertise include every core competency and value-added services across the product lifecycle. 35 years of pioneering the drug delivery industryOver 50 combination products launchedTop 25 bio/pharmaceutical companies in partnership Over 120M SHL devices reached patients worldwide